|
Apr 10
|
Trending tickers: TSMC, Trump Media, US Steel, Novo Nordisk and Tesco
|
|
Apr 9
|
AstraZeneca (LSE:AZN) Gains EU Approval For Breast Cancer Treatment DATROWAY
|
|
Apr 9
|
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
|
|
Apr 9
|
Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’
|
|
Apr 9
|
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca
|
|
Apr 9
|
3 No-Brainer Growth Stocks to Buy for Less Than $100
|
|
Apr 8
|
Astrazeneca (AZN) Stock Moves -1.35%: What You Should Know
|
|
Apr 8
|
AstraZeneca’s camizestrant gains momentum, but questions remain as first-line therapy
|
|
Apr 7
|
AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs
|
|
Apr 7
|
EC approves AstraZeneca’s Imfinzi combo for NSCLC
|
|
Apr 4
|
AstraZeneca (LSE:AZN) Secures EU Approvals; $125 Million Payment Due to Daiichi Sankyo
|
|
Apr 4
|
European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings
|
|
Apr 4
|
European Equities Spiral in Friday Trading Amid Global Selloff Sparked by US Tariffs
|
|
Apr 4
|
Daiichi and AstraZeneca’s Enhertu gains EC approval for breast cancers
|
|
Apr 4
|
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure
|
|
Apr 4
|
AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?
|
|
Apr 1
|
AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication
|
|
Apr 1
|
AstraZeneca’s AZD0780 cuts LDL-C by 50% in Phase IIb trial
|
|
Apr 1
|
Trending tickers: Tesla, Moderna, Newsmax, Johnson & Johnson and Travis Perkins
|
|
Apr 1
|
FDA approves AstraZeneca’s Imfinzi combo for bladder cancer
|